""Medicinos centras „MAXMEDA“ - visus medicinos standartus atitinkanti įstaiga. Ji įsikūrusi Vilniaus naujamiestyje, Mindaugo g. 16"

During the past decade, JSC Gyvenk Silciau Medical Center Maxmeda conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "JSC Gyvenk Silciau Medical Center Maxmeda" are "Endometriosis" (1 trials) and "Uterine Fibroids" (1 trials). Many other conditions were trialed in "JSC Gyvenk Silciau Medical Center Maxmeda" in a lesser frequency.

Most popular intervention types in "JSC Gyvenk Silciau Medical Center Maxmeda" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "BAY1817080" (1 trials), "Elagolix" (1 trials), "Placebo" (1 trials) and "Vilaprisan (BAY1002670)" (1 trials). Other intervention names were less common.

The vast majority of trials in "JSC Gyvenk Silciau Medical Center Maxmeda" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "JSC Gyvenk Silciau Medical Center Maxmeda". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in JSC Gyvenk Silciau Medical Center Maxmeda, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in JSC Gyvenk Silciau Medical Center Maxmeda, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".